Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alessandro Armuzzi and Flavio Caprioli.
Alessandro Armuzzi
Connection Strength
0.550
Flavio Caprioli
  1. COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association. Inflamm Bowel Dis. 2021 Jul 14.
    View in: PubMed
    Score: 0.239
  2. Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey. Inflamm Bowel Dis. 2020 10 23; 26(11):e134-e136.
    View in: PubMed
    Score: 0.057
  3. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. United European Gastroenterol J. 2020 12; 8(10):1228-1235.
    View in: PubMed
    Score: 0.057
  4. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020 07; 69(7):1213-1217.
    View in: PubMed
    Score: 0.055
  5. Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study. Dig Liver Dis. 2019 04; 51(4):510-515.
    View in: PubMed
    Score: 0.050
  6. Unmet needs of Italian physicians managing patients with inflammatory bowel disease. Dig Liver Dis. 2019 02; 51(2):212-217.
    View in: PubMed
    Score: 0.049
  7. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Dig Liver Dis. 2017 04; 49(4):338-358.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.